CSL price action does not look like it will test support this time & I note UBS's recent repot has a 12-month rating 'Buy' with a 12m price target A$41.20/US$38.40.
Their reasons provided include:
�� BAX contemplates price increases & others rebate? Follow reimbursement
�� And the winners are; BAX & CSL…
�� US channel checks mixed – but not on Gammagard Liquid & Carimune
�� Valuation: PT $41.20ps (includes $2.50 cash); Buy rating (unchanged)
CSL daily chart: Price action currently contained within one of those pointy things - wonder if it will break out this time?
CSL price action does not look like it will test support this...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$301.28 |
Change
1.410(0.47%) |
Mkt cap ! $145.1B | |||
| Open | High | Low | Value | Volume |
| $301.73 | $301.80 | $300.71 | $8.632M | 28.61K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 94 | $301.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $301.44 | 130 | 4 |
View Market Depth
| Last trade - 10.06am 12/09/2024 (20 minute delay) ? |
| CSL (ASX) Chart |